FDA Inspection 1152579 — Kimberly Ferrante, MD

Kimberly Ferrante, MD — FEI 3020036631

The FDA completed an inspection of Kimberly Ferrante, MD on September 16, 2021 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Clinical Investigator (CI)